Shire gets injunction against Roche over hemophilia drug

Shire gets injunction against Roche over hemophilia drug

Shire gets injunction against Roche over hemophilia drug

Pharmaceutical group Shire (SHP.L) said on Sunday it had obtained a preliminary injunction in a Hamburg court against rival Roche (ROG.S) over its hemophilia drug emicizumab, alleging incomplete and misleading statements surrounding the treatment. Swiss drugmaker Roche is hoping to win a slice of the $11 billion-a-year hemophilia drug market with emicizumab, also known as ACE910 and designed to compete with more traditional treatments from Novo Nordisk (NOVOb.CO) and Shire.


...Read the rest of this story

Oil could hit $60 before year-end: Barron's, citing Citi analyst

Oil could hit $60 before year-end: Barron's, citing Citi analyst

The report cites research from Citigroup senior energy analyst Eric Lee, who previously called for a bear market in oil when the price was above $100. The decline in recent weeks to a low of just over $44 for Brent crude , the international benchmark, has made Lee a short-term bull, Barron's notes. Simultaneously, reduction in supply from OPEC of about 0.7 million barrels a day versus the 2016 average should drive the price up before the end of the fourth quarter.


...Read the rest of this story

UK-U.S. trade deal will not make up for leaving the EU – minister

UK-U.S. trade deal will not make up for leaving the EU - minister

A post-Brexit trade deal with the United States would not be enough to make up for leaving the European Union, British justice minister David Lidington said on Sunday, tempering Prime Minister Theresa May's enthusiasm about the U.S. offer. May had warmly welcomed assurances on Saturday by U.S. President Donald Trump that a "very powerful" trade deal with Britain would be reached "very, very quickly" after Britain leaves the EU.


...Read the rest of this story